Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Black Sabbath to reunite amid frontman's Parkinson's disease
Ozzy Osbourne's Parkinson's disease 'affected his legs,' Sharon says as his last show looms
Heavy metal star Ozzy Osbourne reveals the date for his final show, which will also reunite the founding members of Black Sabbath after 20 years.
Ozzy Osbourne's final show: Black Sabbath to reunite amid frontman's Parkinson's disease
Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 years.
Ozzy Osbourne to Hit the Stage With Black Sabbath Amid Debilitating Parkinson's Battle
Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U.K.. Osbourne, 76, has been battling Parkinson's disease for years, but the Prince of Darkness will not let that keep him from the stage.
Daniel Barenboim, Parkinson's disease
Conductor Daniel Barenboim says he's been diagnosed with Parkinson's disease
Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday on Instagram. He has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner’s Ring Cycle in Berlin.
Daniel Barenboim Announces He Has Parkinson’s Disease
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, said Thursday that he has Parkinson’s disease.
Conductor Daniel Barenboim reveals his Parkinson's disease diagnosis
The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's Ring Cycle in Berlin.
Medscape
16h
Despite Early Promise GLP-1 Disappoints in Parkinson’s Disease
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
Pharm Exec
2h
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
healthday
5h
Study Finds Exenatide Not Beneficial for Parkinson Disease
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease seve ...
1d
FDA approves wearable infusion device for advanced Parkinson disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Healio
2d
GLP-1 does not slow Parkinson’s disease progression in phase 3 study
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
Rolling Out
8d
A breakthrough in Parkinson’s disease detection
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
2d
Drug Similar to Ozempic Failed to Treat Parkinson’s Disease in a Trial
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
9h
on MSN
Ozzy Osbourne crippled by disease, to perform one last time with iconic band
Sharon Osbourne, his wife, told The Sun her husband’s voice is still up to the task of performing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Ozzy Osbourne
Black Sabbath
Ozempic
Daniel Barenboim
Onapgo
Feedback